| Ambetter Health Texas Superior Marketplace Clinical | Lecanemab-irmb | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Lanreotide | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Lapatinib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Lazertinib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Lebrikizumab | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Lenvatinib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Leniolisib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Leucovorin | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Leuprolide Acetate, Leuprolide Mesylate | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Levacetylleucine | 2025-11-01 |